Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 10, 2025
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
GlobeNewswire
·
March 10, 2025
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that …
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025
GlobeNewswire
·
March 10, 2025
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025 Mont-Saint-Guibert, Belgique – 10 mars 2025, 22h05 CET / 17h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société …
Viemed Healthcare Announces Record 2024 Financial Results
GlobeNewswire
·
March 10, 2025
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its …
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 10, 2025
SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Turkish Dried Apricots Supplier and Exporter Named the one of the Biggest in the Industry
EIN Presswire
·
March 10, 2025
Turkey’s rich agricultural history is deeply intertwined with apricot cultivation. Malatya city, often referred to as the “apricot capital of the world'' MALATYA, BATTALGAZI, TURKEY, March 10, 2025 /EINPresswire.com/ -- Dried apricots have long been a …
Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 10, 2025
– Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures – – UDENYCA® net revenue increased 62% year-over-year – – LOQTORZI® net revenue increased 29% quarter-over-quarter – – UDENYCA divestiture on track with Special …
FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
GlobeNewswire
·
March 10, 2025
New York, March 10, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients aged six …
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 10, 2025
— PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary data in December 2024 — Expansion of PI3Ka franchise to include a pan-mutant …
The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025
GlobeNewswire
·
March 10, 2025
SAN JUAN CAPISTRANO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
GlobeNewswire
·
March 10, 2025
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change from baseline in Clinical Dementia Rating Sum of Boxes (CDR …
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 10, 2025
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker Presentation at the American College of Cardiology Meeting …
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
March 10, 2025
RADNOR, Pa., March 10, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
March 10, 2025
NEWTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …
A' Medical Devices and Medical Equipment Design Award Announces Final Call for Entries
EIN Presswire
·
March 10, 2025
The Prestigious A' Medical Devices and Medical Equipment Design Award Extends Last Entry Period Until March 30, 2025 COMO, CO, ITALY, March 10, 2025 /EINPresswire.com/ -- The A' Medical Devices and Medical Equipment Design Award, a highly regarded …
Cancer Biologics Market Projected To Witness Substantial Growth 2025-2032:Amgen Inc., Pfizer Inc., Sanofi S.A, Bayer AG
EIN Presswire
·
March 10, 2025
Biologic drug is a product that contain components of living organisms such as animal, human, or produced from living organisms. BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Latest Report, titled “Cancer Biologics Market” Trends, …
Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi Biotech, Ciloa
EIN Presswire
·
March 10, 2025
Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a CAGR of 28.5% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
Revenue Cycle Management Market Projected To Witness Substantial Growth, 2025-2032: Experian Health, Veradigm LLC
EIN Presswire
·
March 10, 2025
Revenue Cycle Management Market is estimated to be valued at USD 175.50 Bn in 2025 and is expected to reach USD 388.21 Bn by 2032, exhibiting a CAGR of 12.0%. BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Latest Report, titled “ …
Proteomics Market Projected To Witness Substantial Growth, 2025-2032: Bio-Rad Laboratories, Inc., GE Healthcare, Bruker
EIN Presswire
·
March 10, 2025
Proteomics is a study of large scale proteomes. Proteomes are entire complements of protein expressed by a tissue, cell or organism. BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Latest Report, titled “Proteomics Market” Trends, …
Lab Information Management Systems Market Size to Achieve USD 4.15 Billion by 2031, Fueled by a CAGR of 10.9%: Says AMR
EIN Presswire
·
March 10, 2025
Rise in research …
Social Determinants of Health Market Is Booming Worldwide 2025-2032: Orion Health, Signify Health, Arcadia Group
EIN Presswire
·
March 10, 2025
Social Determinants of Health Market size is expected to reach US$ 18.06 Bn by 2030, from US$ 5.57 Bn in 2023, exhibiting a CAGR of 18.3%. BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- Latest Report, titled “Social Determinants of …